Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
July 19, 2021
Working towards full eradication of lipid-driven cardiovascular risk?
N S Nurmohamed, E S G Stroes
The Netherlands Journal of Medicine
|
May 29, 2013
Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises
J Besseling, G K Hovingh, E S G Stroes
The Netherlands Journal of Medicine
|
September 22, 2009
Where the immune response meets the vessel wall
R J Bisoendial, E S G Stroes, P P Tak
Current Pharmaceutical Design
|
January 16, 2013
The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease
A E Bochem, J A Kuivenhoven, E S G Stroes
Nederlands Tijdschrift Voor Geneeskunde
|
November 17, 2020
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
R M Hoogeveen, E S G Stroes, J H Cornel
Current Pharmaceutical Design
|
January 14, 2011
Critical determinants of cardiovascular risk in rheumatoid arthritis
R J Bisoendial, E S G Stroes, P P Tak
Diabetes, Obesity & Metabolism
|
October 11, 2007
Normalization of metabolic syndrome using fenofibrate, metformin or their combination
M Nieuwdorp, E S G Stroes, J J P Kastelein, et al.
Expert Review of Cardiovascular Therapy
|
June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia
N S Nurmohamed, G M Dallinga-Thie, E S G Stroes
The Netherlands Journal of Medicine
|
November 13, 2013
Intestinal cholesterol secretion: future clinical implications
L Jakulj, J Besseling, E S G Stroes, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2008
Combination statin-fibrate therapy: safety aspects
R Franssen, M Vergeer, E S G Stroes, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
July 19, 2021
Working towards full eradication of lipid-driven cardiovascular risk?
N S Nurmohamed, E S G Stroes
The Netherlands Journal of Medicine
|
May 29, 2013
Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises
J Besseling, G K Hovingh, E S G Stroes
The Netherlands Journal of Medicine
|
September 22, 2009
Where the immune response meets the vessel wall
R J Bisoendial, E S G Stroes, P P Tak
Current Pharmaceutical Design
|
January 16, 2013
The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease
A E Bochem, J A Kuivenhoven, E S G Stroes
Nederlands Tijdschrift Voor Geneeskunde
|
November 17, 2020
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
R M Hoogeveen, E S G Stroes, J H Cornel
Current Pharmaceutical Design
|
January 14, 2011
Critical determinants of cardiovascular risk in rheumatoid arthritis
R J Bisoendial, E S G Stroes, P P Tak
Diabetes, Obesity & Metabolism
|
October 11, 2007
Normalization of metabolic syndrome using fenofibrate, metformin or their combination
M Nieuwdorp, E S G Stroes, J J P Kastelein, et al.
Expert Review of Cardiovascular Therapy
|
June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia
N S Nurmohamed, G M Dallinga-Thie, E S G Stroes
The Netherlands Journal of Medicine
|
November 13, 2013
Intestinal cholesterol secretion: future clinical implications
L Jakulj, J Besseling, E S G Stroes, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2008
Combination statin-fibrate therapy: safety aspects
R Franssen, M Vergeer, E S G Stroes, et al.
Page
of 4